You are currently browsing the archives for 15 January 2015.
Displaying 1 - 2 of 2 entries.

The risk of postmenopausal breast cancer.

Found in a previous study published in Cancer Epidemiology Biomarkers Prevention to reduce the daily consumption of dairy products, the risk of postmenopausal breast cancer. The authors suggest that calcium and vitamin D in dairy products may reduce the risk of cancer through both a direct effect on cell proliferation and hormones.

The results? Women with a very low blood levels of 25 D had a significantly increased risk of breast cancer.The anti-cancer properties of vitamin D can be influenced by the fact, described the vitamin cell growth, cell differentiation, and programmed cell death . Researchers led by Dr. Jenny Chang headed had, also suggests that vitamin D can exert its cancer-preventing effect by counteracting the growth – stimulating effect of estrogens. ‘Our results have a protective effect for postmenopausal breast cancer defined with a better vitamin D supply,’the scientists concluded.

1 percent from 2007 user reviews.

Ramin said that his agency has found that 14 percent of drug users in the capital Phnom Penh were HIV-positive in 2006 – a figure which 35.1 percent 35.1 percent from 2007 user reviews .

The trial was initiated in July 2008 in leading bronchiectasis centers in the United Kingdom and completed a total of 36 patients scheduled. The subjects were two different doses of once-daily inhaled liposomal ciprofloxacin in a parallel design for a treatment period of 28 consecutive days were randomized. The primary efficacy endpoint of the study is the change from baseline in the sputum Pseudomonas aeruginosa colony forming units over the treatment period, an objective measure of the reduction in pulmonary bacterial load. Other endpoints include measurements of lung function and respiratory symptoms. Approximately 110,000 with the completion of enrollment of this study is an important milestone in the development of inhaled liposomal ciprofloxacin satisfied and want the investigators for the punctual and rapid application thanks We await publication of the data from the study in the first quarter of 2009,’said Tunde Otulana, Aradigm Chief Medical Officer.